Back
BridgeBio Pharma Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
BBIO
BridgeBio Pharma
Last Price:
$34.05
Seasonality Move:
1.07%
7 Day Trial
ALL ACCESS PASS
$
7

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
-
The current trend is moderately bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.5 | Sell |
20-day SMA: | 33.97 | Sell |
50-day SMA: | 34.25 | Sell |
200-day SMA: | 28.34 | Buy |
8-day EMA: | 34.7 | Sell |
20-day EMA: | 34.4 | Sell |
50-day EMA: | 33.38 | Sell |
200-day EMA: | 29.88 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 45.09 | Sell |
Chaikin Money Flow: | -2384935 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.46 - 35.48) | Sell |
Bollinger Bands (100): | (26.48 - 34.92) | Buy |
BridgeBio Pharma Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.02 while BBIO 8-day simple moving average is 35.50, which is a Sell signal.
-
The stock price of BBIO is 33.02 while BridgeBio Pharma 20-day SMA is 33.97, which makes it a Sell.
-
BridgeBio Pharma 50-day simple moving average is 34.25 while BBIO share price is 33.02, making it a Sell technically.
-
BBIO stock price is 33.02 and BridgeBio Pharma 200-day simple moving average is 28.34, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
28
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $33.02. The Score for BBIO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
6.3B
Price in USD:
33.02
Share Volume:
3M
BridgeBio Pharma 52-Week Range
52-Week High:
39.47
52-Week Low:
21.62
Sell
28
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 33.02 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.02 while BBIO 8-day exponential moving average is 34.70, which is a Sell signal.
-
The stock price of BBIO is 33.02 while BridgeBio Pharma 20-day EMA is 34.40, which makes it a Sell.
-
BridgeBio Pharma 50-day exponential moving average is 33.38 while BBIO share price is 33.02, making it a Sell technically.
-
BBIO stock price is 33.02 and BridgeBio Pharma 200-day simple moving average is 29.88, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.05 per share, a decrease this year of $1.15 per share, and an increase next year of $0.70 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 45.09, which suggest BridgeBio Pharma is oversold
-
The Bollinger Bands (25) for BridgeBio Pharma is (32.46 - 35.48), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (26.48 - 34.92), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.